Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 82
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
220 Patients or 20,000? Clinics Split on Psychedelics’ First Year
Robert Rush: Emergency Scheduling, 7-OH, and the War on Research
Breaking: Compass Files Psilocybin for TRD New Drug Application with FDA
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Colorado Department of Revenue Natural Medicine Division Listening Sessions: Round 2
PT481 – Kanna: The History, Science, and Potential of an Emerging...
Pα+ Psychedelic Bulletin #154: Public & Industry Respond to DEA’s Renewed...
Ensuring the Affordable Becomes Accessible – Lessons from Ketamine’s Antidepressant Development...
European Union Grants €6.5M for Multi-Site Psilocybin Study in Palliative Patients
PT480 – Psychedelics and Consent: Power Dynamics, Boundaries, and the Concept...
The Psychedelic News Feed: Dec 11 2023 – Jan 7, 2024
Psychedelics M&A and Partnerships in 2023
PT479 – Psilocybin in the Midwest and the Need for Potency...
Psychedelic Funding & Public Markets in 2023
Load more